CliffBio
small molecule

BONJESTA

DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE

Loss of exclusivityFebruary 2033latest FDA-listed patent expiry
CompanyDuchesnay Usa →View the full company profile on CliffBio

Drug detail

Brand nameBONJESTA
Active ingredientDOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
Strength20MG;20MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalNovember 2016
Marketing statusRX

Listed patents

PatentExpiresType
9937132February 2033product
9375404February 2033product
9526703February 2033product
9089489February 2033product

More from Duchesnay Usa

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

BONJESTA patent cliff — loss of exclusivity February 2033 | CliffBio